Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
14.51
-0.05 (-0.34%)
At close: Feb 11, 2026, 4:00 PM EST
14.52
+0.01 (0.07%)
Pre-market: Feb 12, 2026, 7:09 AM EST
Aurinia Pharmaceuticals Employees
Aurinia Pharmaceuticals had 130 employees as of December 31, 2024. The number of employees decreased by 170 or -56.67% compared to the previous year.
Employees
130
Change (1Y)
-170
Growth (1Y)
-56.67%
Revenue / Employee
$2,044,677
Profits / Employee
$598,746
Market Cap
1.91B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 130 | -170 | -56.67% |
| Dec 31, 2023 | 300 | 0 | - |
| Dec 31, 2022 | 300 | 0 | - |
| Dec 31, 2021 | 300 | 6 | 2.04% |
| Dec 31, 2020 | 294 | 232 | 374.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Zai Lab | 1,869 |
| Sarepta Therapeutics | 1,372 |
| MannKind | 407 |
| Ardelyx | 395 |
| Vericel | 357 |
| Nuvation Bio | 291 |
| Syndax Pharmaceuticals | 270 |
| Stoke Therapeutics | 128 |
AUPH News
- 3 months ago - Aurinia Pharmaceuticals Inc. (AUPH) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Aurinia Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2025 and Provides Update on Recent Business Progress - Business Wire
- 3 months ago - Wall Street Breakfast Podcast: FDA Executive Controversy - Seeking Alpha
- 3 months ago - Aurinia Pharmaceuticals to Report Financial Results for the Three and Nine Months Ended September 30, 2025 and Provide Update on Recent Business Progress on November 4, 2025 - Business Wire
- 4 months ago - Aurinia Pharmaceuticals: Lupkynis Growth And AUR200 Pipeline Justify Buy Rating - Seeking Alpha
- 4 months ago - Aurinia Announces Upcoming Presentations of New Data on LUPKYNIS® at American College of Rheumatology Convergence and American Society of Nephrology Kidney Week 2025 - Business Wire
- 4 months ago - Aurinia Responds to Now Retracted LinkedIn Post - Business Wire
- 6 months ago - Aurinia Pharma: The Easiest Money May Have Been Made (Rating Downgrade) - Seeking Alpha